HopeStage
Back to all studies
Not Yet RecruitingNCT07664631

Effects of Stimulant Medications in PTSD

Medication studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
ChicagoSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: September 15, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
40
Sponsor
University of Chicago
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT07664631
Official title
Show the full official title

Effects of Stimulant Medications in PTSD

Recruitment & locations

Not yet recruiting

Chicago

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Chicago, a university.

Does this study involve medication?

Yes. The study involves medication, including Placebo and Adderall.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies